BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10840163)

  • 1. Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells.
    Tomita T; Fujii M; Tokumaru Y; Imanishi Y; Kanke M; Yamashita T; Ishiguro R; Kanzaki J; Kameyama K; Otani Y
    Cancer Lett; 2000 Aug; 156(1):83-91. PubMed ID: 10840163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
    Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N
    Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage-colony stimulating factor stimulates tumor invasiveness in squamous cell lung carcinoma.
    Tsuruta N; Yatsunami J; Takayama K; Nakanishi Y; Ichinose Y; Hara N
    Cancer; 1998 Jun; 82(11):2173-83. PubMed ID: 9610697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony stimulating factor induces endothelial capillary formation through induction of membrane-type 1 matrix metalloproteinase expression in vitro.
    Krubasik D; Eisenach PA; Kunz-Schughart LA; Murphy G; English WR
    Int J Cancer; 2008 Mar; 122(6):1261-72. PubMed ID: 18027871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
    Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
    Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
    Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
    Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts.
    Tokumaru Y; Fujii M; Otani Y; Kameyama K; Imanishi Y; Igarashi N; Kanzaki J
    Cancer Lett; 2000 Mar; 150(1):15-21. PubMed ID: 10755382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate.
    Heikkilä P; Teronen O; Hirn MY; Sorsa T; Tervahartiala T; Salo T; Konttinen YT; Halttunen T; Moilanen M; Hanemaaijer R; Laitinen M
    J Surg Res; 2003 May; 111(1):45-52. PubMed ID: 12842447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
    Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.
    Yoshizaki T; Sato H; Maruyama Y; Murono S; Furukawa M; Park CS; Seiki M
    Cancer; 1997 Jan; 79(1):139-44. PubMed ID: 8988738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
    Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells.
    Sugimoto C; Fujieda S; Sunaga H; Noda I; Tanaka N; Kimura Y; Saito H; Matsukawa S
    Int J Cancer; 2001 Jul; 93(1):42-6. PubMed ID: 11391619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism.
    Gingras D; Pagé M; Annabi B; Béliveau R
    Biochim Biophys Acta; 2000 Sep; 1497(3):341-50. PubMed ID: 10996658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated Src and Janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells.
    Zgheib A; Lamy S; Annabi B
    J Biol Chem; 2013 May; 288(19):13378-86. PubMed ID: 23548906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer.
    Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T
    Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression.
    Gutschalk CM; Yanamandra AK; Linde N; Meides A; Depner S; Mueller MM
    Cancer Med; 2013 Apr; 2(2):117-29. PubMed ID: 23634280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells.
    Chegini N; Tang XM; Ma C
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4138-43. PubMed ID: 10566662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
    Luo XH; Liao EY
    Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.